Sarah Warburton

Title: Innovations by Sarah Warburton in Drug Target Identification

Introduction

Sarah Warburton is an accomplished inventor based in Los Angeles, CA. She has made significant contributions to the field of drug target identification through her innovative methods. Her work focuses on improving the efficiency and accuracy of identifying drug targets, which is crucial for the development of effective therapies.

Latest Patents

Warburton holds a patent for a method titled "Ligand binding stabilization method for drug target identification." This method, known as Drug Affinity Responsive Target Stability (DARTS), offers several advantages over existing techniques. The process involves contacting a sample containing one or more protein targets with a test agent to create a sample/test agent mixture. This mixture is then treated with a protease, allowing for the identification of proteins or protein fragments that are protected from proteolysis. The protection from proteolysis serves as an indicator that the protein or protein fragment interacts with the test agent. Warburton's innovative approach has the potential to enhance drug discovery processes significantly.

Career Highlights

Warburton is affiliated with the University of California, where she continues to advance her research in drug target identification. Her work has garnered attention for its potential to streamline the drug development process and improve therapeutic outcomes.

Collaborations

Some of her notable coworkers include Jing Huang and Mariam Aghajan, who contribute to the collaborative efforts in her research endeavors.

Conclusion

Sarah Warburton's innovative contributions to drug target identification exemplify the impact of her work in the field of pharmaceuticals. Her patented method, DARTS, represents a significant advancement in the identification of drug targets, paving the way for more effective drug development.